Skip to content

Clinical trials

Phase 3 Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 3 Country / region: United States Clear all

247 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20013
20022
20035
200410
200511
200613
200711
200810
20099
201017
20113
20126
20136
20145
201511
20167
20177
201816
201914
202010
20217
202210
20237
20244
20257
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed124
Terminated44
Active, not recruiting33
Recruiting25
Withdrawn8
Unknown status7
Enrolling by invitation3
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie16
Novartis Pharmaceuticals12
Amgen8
AstraZeneca8
Sanofi6
GlaxoSmithKline5
Pfizer5
Alliance for Clinical Trials in Oncology4
Astellas Pharma Global Development, Inc.4
Bayer4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms247
Neoplasm Metastasis29
Breast Neoplasms23
Neoplasms by Site19
Prostatic Neoplasms18
Pain16
Carcinoma14
Carcinoma, Non-Small-Cell Lung14
Multiple Myeloma14
Lymphoma, Non-Hodgkin13

Trials

Showing 1 to 25 of 247. Each trial links to its page on Pharma Observatory.

147 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.